394 related articles for article (PubMed ID: 18252757)
1. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome.
Petitprez S; Jespersen T; Pruvot E; Keller DI; Corbaz C; Schläpfer J; Abriel H; Kucera JP
Cardiovasc Res; 2008 Jun; 78(3):494-504. PubMed ID: 18252757
[TBL] [Abstract][Full Text] [Related]
2. A novel mutation in the SCN5A gene is associated with Brugada syndrome.
Shin DJ; Kim E; Park SB; Jang WC; Bae Y; Han J; Jang Y; Joung B; Lee MH; Kim SS; Huang H; Chahine M; Yoon SK
Life Sci; 2007 Jan; 80(8):716-24. PubMed ID: 17141278
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation.
Casini S; Tan HL; Bhuiyan ZA; Bezzina CR; Barnett P; Cerbai E; Mugelli A; Wilde AA; Veldkamp MW
Cardiovasc Res; 2007 Dec; 76(3):418-29. PubMed ID: 17854786
[TBL] [Abstract][Full Text] [Related]
4. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation.
Keller DI; Huang H; Zhao J; Frank R; Suarez V; Delacrétaz E; Brink M; Osswald S; Schwick N; Chahine M
Cardiovasc Res; 2006 Jun; 70(3):521-9. PubMed ID: 16616735
[TBL] [Abstract][Full Text] [Related]
5. Mutation-specific effects of lidocaine in Brugada syndrome.
Clancy CE; Wehrens XH
Int J Cardiol; 2007 Oct; 121(3):249-52. PubMed ID: 17761312
[TBL] [Abstract][Full Text] [Related]
6. The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases.
Six I; Hermida JS; Huang H; Gouas L; Fressart V; Benammar N; Hainque B; Denjoy I; Chahine M; Guicheney P
Europace; 2008 Jan; 10(1):79-85. PubMed ID: 18156160
[TBL] [Abstract][Full Text] [Related]
7. Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization.
Watanabe H; Nogami A; Ohkubo K; Kawata H; Hayashi Y; Ishikawa T; Makiyama T; Nagao S; Yagihara N; Takehara N; Kawamura Y; Sato A; Okamura K; Hosaka Y; Sato M; Fukae S; Chinushi M; Oda H; Okabe M; Kimura A; Maemura K; Watanabe I; Kamakura S; Horie M; Aizawa Y; Shimizu W; Makita N
Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):874-81. PubMed ID: 22028457
[TBL] [Abstract][Full Text] [Related]
8. A paradoxical effect of lidocaine for the N406S mutation of SCN5A associated with Brugada syndrome.
Itoh H; Tsuji K; Sakaguchi T; Nagaoka I; Oka Y; Nakazawa Y; Yao T; Jo H; Ashihara T; Ito M; Horie M; Imoto K
Int J Cardiol; 2007 Oct; 121(3):239-48. PubMed ID: 17445919
[TBL] [Abstract][Full Text] [Related]
9. A sodium channel pore mutation causing Brugada syndrome.
Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
[TBL] [Abstract][Full Text] [Related]
10. SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome.
Probst V; Wilde AA; Barc J; Sacher F; Babuty D; Mabo P; Mansourati J; Le Scouarnec S; Kyndt F; Le Caignec C; Guicheney P; Gouas L; Albuisson J; Meregalli PG; Le Marec H; Tan HL; Schott JJ
Circ Cardiovasc Genet; 2009 Dec; 2(6):552-7. PubMed ID: 20031634
[TBL] [Abstract][Full Text] [Related]
11. [Novel SCN5A gene mutations associated with Brugada syndrome: V95I, A1649V and delF1617].
Liang P; Liu WL; Hu DY; Li CL; Tao WH; Li L
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):616-9. PubMed ID: 17081365
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more?
Meregalli PG; Wilde AA; Tan HL
Cardiovasc Res; 2005 Aug; 67(3):367-78. PubMed ID: 15913579
[TBL] [Abstract][Full Text] [Related]
13. Clinical aspects and physiopathology of Brugada syndrome: review of current concepts.
Herbert E; Chahine M
Can J Physiol Pharmacol; 2006; 84(8-9):795-802. PubMed ID: 17111025
[TBL] [Abstract][Full Text] [Related]
14. [Detection of gene mutations of SCN5A in 7 patients with Brugada syndrome].
Yuan BB; Shan QJ; Yang B; Chen ML; Zou JG; Chen C; Xu DJ; Cao KJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 May; 36(5):404-7. PubMed ID: 19100032
[TBL] [Abstract][Full Text] [Related]
15. High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis.
Lambiase PD; Ahmed AK; Ciaccio EJ; Brugada R; Lizotte E; Chaubey S; Ben-Simon R; Chow AW; Lowe MD; McKenna WJ
Circulation; 2009 Jul; 120(2):106-17, 1-4. PubMed ID: 19564561
[TBL] [Abstract][Full Text] [Related]
16. Abnormal restitution property of action potential duration and conduction delay in Brugada syndrome: both repolarization and depolarization abnormalities.
Nishii N; Nagase S; Morita H; Kusano KF; Namba T; Miura D; Miyaji K; Hiramatsu S; Tada T; Murakami M; Watanabe A; Banba K; Sakai Y; Nakamura K; Oka T; Ohe T
Europace; 2010 Apr; 12(4):544-52. PubMed ID: 20083482
[TBL] [Abstract][Full Text] [Related]
17. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
[TBL] [Abstract][Full Text] [Related]
18. Subepicardial phase 0 block and discontinuous transmural conduction underlie right precordial ST-segment elevation by a SCN5A loss-of-function mutation.
Bébarová M; O'Hara T; Geelen JL; Jongbloed RJ; Timmermans C; Arens YH; Rodriguez LM; Rudy Y; Volders PG
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H48-58. PubMed ID: 18456723
[TBL] [Abstract][Full Text] [Related]
19. Criteria to predict carriers of a novel SCN5A mutation in a large Portuguese family affected by the Brugada syndrome.
Santos LF; Rodrigues B; Moreira D; Correia E; Nunes L; Costa A; Elvas L; Pereira T; Machado JC; Castedo S; Henriques C; Matos A; Santos JO
Europace; 2012 Jun; 14(6):882-8. PubMed ID: 22277643
[TBL] [Abstract][Full Text] [Related]
20. Facilitatory and inhibitory effects of SCN5A mutations on atrial fibrillation in Brugada syndrome.
Amin AS; Boink GJ; Atrafi F; Spanjaart AM; Asghari-Roodsari A; Molenaar RJ; Ruijter JM; Wilde AA; Tan HL
Europace; 2011 Jul; 13(7):968-75. PubMed ID: 21273195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
